Early breast cancer treatment before surgery
For some people with early breast cancer, it may be beneficial to start treatment before having surgery. This is called neoadjuvant treatment.
Prior to surgery, PERJETA is approved for use in combination with Herceptin® (trastuzumab) and chemotherapy in people with HER2+, locally advanced, inflammatory, or early stage breast cancer (tumor greater than 2 cm in diameter or node-positive). PERJETA should be used as part of a complete treatment regimen for early breast cancer.